Caplin Point Laboratories Ltd (BOM:524742)
₹ 2009.45 -0.9 (-0.04%) Market Cap: 152.74 Bil Enterprise Value: 144.03 Bil PE Ratio: 31.01 PB Ratio: 6.01 GF Score: 98/100

Q4 2023 Caplin Point Laboratories Ltd Earnings Call Transcript

May 27, 2023 / 10:30AM GMT
Operator

Ladies and gentlemen, good day and welcome to Q4 and FY 2023 Earnings Conference Call of Caplin Point Laboratories, hosted by Ambit Capital. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Prashant Nair from AMBIT Capital. Thank you and over to you.

Prashant Nair;Partheeban Vivek Siddarth
AMBIT Capital Private Limited, Research Division - Research Analyst;Caplin Point

Thanks a lot, Tejaswi. Good afternoon, everyone and thank you for dialing-in. I am Prashant Nair, healthcare analyst from AMBIT Capital. I would like to thank the Caplin Point management for giving us the opportunity to host this call. From the management team today we have with us Mr. Shri. C.C. Paarthipan, Chairman; Mr. Vivek Partheeban, Chief Operating Officer; Dr. Sridhar Ganesan, Managing Director; Mr. D. Muralidharan, CFO and Mr. M. Sathyanarayanan, Deputy CFO.

I will now hand over the call to Vivek for his opening remarks, post which we can go to Q&A. Over to you, Vivek.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot